Stem-cell sacs reduced aging markers in human skin cells
In repeatedly divided human skin cells grown in the lab, the sacs reduced the share testing positive for a senescence marker by 70% versus untreated cells.
Limit: Senescence-marker positivity is a stand-in for healthier skin, not a direct measure
Edited by Boris Djordjevic · AgingResearch.News
Human dermal fibroblasts—cells that help support skin—received tiny membrane sacs made from human tonsil stem cells in laboratory experiments. Researchers selected stem cells carrying CD146, a surface protein that identifies a subgroup. Repeated cell division induced senescence, a state in which cells stop dividing. The sacs reduced the share positive for a senescence marker by 70% compared with untreated cells in this model.
Tests also included surgically removed human skin exposed to ultraviolet B light and nine female mice: two aged 2 months and seven aged 26 months. Mice given sacs received two 150-microgram injections seven days apart; researchers examined tissues two weeks after the final injection. In old mice given selected-cell sacs, skin collagen fibers appeared more organized.
Why it matters
Cell senescence is a target for research on age-related tissue dysfunction. The authors proposed these sacs as a potential therapeutic approach.
Caveats
These marker-based laboratory results do not establish benefits in people; only two old mice received the selected-cell sacs. In removed human skin, the higher dose—100 micrograms per milliliter—did not consistently improve skin-barrier markers and lowered one.
The paper
Ltd; Yonsei University
Biomaterials Research, Jan 1, 2026, Open access
